Evidence map›Paper›PMID 41945619›Full record

ArticlePloS one2026

Optical quality of Fresnel-structured hyperopic implantable collamer lenses: A ray-tracing analysis.

Kimiya Shimizu, Takushi Kawamorita

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kimiya ShimizuDepartment of Eye Center, Sanno Hospital, Minato-ku, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5833-5602
Takushi KawamoritaDepartment of Orthoptics and Visual Science, Kitasato University, Sagamihara, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-3759-0775

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To achieve positive refractive power, implantable collamer lenses (ICLs) for hyperopia increase central thickness, which in turn raises the risk of pupil blockage and lens contact in eyes with shallow anterior chambers. Additionally, incorporating a central hole raises concerns about stray light and halo formation due to increased thickness. This study used optical simulation to evaluate the imaging performance of hyperopic ICLs, highlighting the Fresnel structure's potential to reduce thickness while maintaining imaging performance. Optical simulations were performed using Ansys Zemax OpticStudio 2024 R2 (Ansys, Inc.). An ICL with +10.00 D correction was designed for the Liou & Brennan model eye. The vault was set to 0.50 mm, and the central hole diameter was set to 0.36 mm. Fresnel ICLs (Fr. ICLs) with step heights ranging from 25 to 100 µm were compared with the reference ICL (Ref. ICL). Modulation transfer function (MTF) analyses were performed at internal artificial pupil diameters of 3.00 mm and 4.50 mm, both with and without holes. By reducing the central thickness from 0.80 mm to 0.40 mm, the Fr. ICL for hyperopia showed higher MTF values than the Ref. ICL at both pupil diameters. The difference was particularly significant at 4.50 mm. A slight MTF decrease due to the central hole was observed at 3.00 mm internal artificial pupil diameter. A step height of 50 µm or more suppressed contrast reduction at high spatial frequencies. Although further research is needed in illumination optics and clinical studies, ray-tracing simulations have demonstrated that the designed hyperopia-correcting Fr. ICL can reduce central thickness while maintaining or improving optical performance, making it a promising candidate for clinical application.

Indexed as

HyperopiaPhakic Intraocular LensesComputer SimulationHumansRefraction, Ocular

Identifiers

PMID41945619
PMCPMC13056176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.